Ga-68 Galmydar
N/A
Report date: 2026/03/11 20:02:12
NME
Base Information
Drug NameGa-68 Galmydar
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWashington University School Of Medicine
China Registration ClassN/A
Develop Information
Active CompaniesNational Institutes Of HealthWashington University School Of MedicineNational Heart, Lung, And Blood Institute (Nhlbi)
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A